Scoliosis: Unmet Need Spawns Device Innovation
Executive SummaryThe once high-flying spine market has been brought down to earth recently as industrywide pressures from regulatory approval to payor reimbursement have altered the outlook on profits. These changes can be especially hard on specialized areas of the market such as the scoliosis field, where a great deal of innovation is still in the research stages at universities and start-up companies.
You may also be interested in...ï»¿
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.